- Featured Product
- KD/KO Validated
Cyclin D1 Polyclonal antibody
Cyclin D1 Polyclonal Antibody for FC (Intra), IF, IHC, WB, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human, mouse, rat and More (3)
Applications
WB, IHC, IF, FC (Intra), ELISA
Conjugate
Unconjugated
251
Cat no : 26939-1-AP
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | LNCaP cells, MCF-7 cells, C6 cells |
Positive IHC detected in | human ovary tumor tissue, human oesophagus cancer tissue, human lung cancer tissue, mouse spleen tissue, mouse pancreas tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Positive IF detected in | MCF-7 cells |
Positive FC detected in | MCF-7 cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
Immunohistochemistry (IHC) | IHC : 1:750-1:3000 |
Immunofluorescence (IF) | IF : 1:200-1:800 |
Sample-dependent, check data in validation data gallery |
Published Applications
KD/KO | See 2 publications below |
WB | See 248 publications below |
IHC | See 14 publications below |
IF | See 2 publications below |
Product Information
The immunogen of 26939-1-AP is Cyclin D1 Fusion Protein expressed in E. coli.
Tested Reactivity | human, mouse, rat |
Cited Reactivity | human, mouse, rat, canine, pig, sheep |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | Cyclin D1 fusion protein Ag25393 |
Full Name | cyclin D1 |
Calculated molecular weight | 295 aa, 34 kDa |
Observed molecular weight | 34 kDa |
GenBank accession number | BC000076 |
Gene symbol | CCND1 |
Gene ID (NCBI) | 595 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
CCND1 (cyclin D1), also known as PRAD1 or BCL1, belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. CCND1 forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. The CCND1 gene, located on 11q13 has been reported to be overexpressed in mantle cell lymphoma (MCL) due to the chromosomal translocation. CCND1 has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Over-expression of CCND1 is known to correlate with the early onset of cancer and risk of tumor progression and metastasis.
Protocols
Product Specific Protocols | |
---|---|
WB protocol for Cyclin D1 antibody 26939-1-AP | Download protocol |
IHC protocol for Cyclin D1 antibody 26939-1-AP | Download protocol |
IF protocol for Cyclin D1 antibody 26939-1-AP | Download protocol |
FC protocol for Cyclin D1 antibody 26939-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Mol Cancer LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer. | ||
J Pineal Res Melatonin modulates metabolic remodeling in HNSCC by suppressing MTHFD1L-formate axis. | ||
Nat Commun Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma. | ||
J Crohns Colitis M2 macrophage-derived exosomal-miR-590-3p attenuates DSS-induced mucosal damage and promotes epithelial repair via the LATS1/YAP/β-catenin signalling axis. | ||
Oncogene Disrupted mitochondrial homeostasis coupled with mitotic arrest generates antineoplastic oxidative stress | ||
Clin Transl Med FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy. |